Treatment of Late stent thrombosis
SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.
Optimal revascularization strategy in patients with three-vessel disease and/or left main disease The 2-year Outcomes of the SYNTAX Trial A. Pieter Kappetein,
Bare Metal Stents
Outcomes of the Polymer-based, Paclitaxel-eluting TAXUS Stent in Complex Lesions Principal Clinical and Angiographic Results from the TAXUS-V Pivotal Randomized.
TCT 2011 Temas Destacados Dr.Juan Gaspar Montevideo – Uruguay [email protected].
